___

• 1. World Health Organization: Hepatitis B. World Health Organization fact sheet 204 (revised October 2000). Available at http:/who.int/inf-fs/en/fact204.html. (Accessed on March 2009).
• 2. Borkowsky W, Krugman S. Viral Hepatitis: A, B, C, D, E and newer hepatitis agents. In: Katz SL, Gershon AA, Hotez PJ (editors). Krugman's Infectious Diseases of Children. 10 th ed. Inc St.Louis: Mosby-year Book; 1998.pp.157-87.
• 3. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009: 49; 45-55.
• 4. Üstün C, Basugay E, Deveci U. seroprevalence of hepatitis B and hepatitis C in children admitted to pediatric surgery policlinic. Nobel Medicus 2009; 5: 4-9.
• 5. Chotiyaputta W, Lok AS. Role of antiviral therapy in the prevention of perinatal transmission of hepatitis b virus infection. J Viral Hepat 2009; 16: 91-3.
• 6. Tran TT. Hepatitis B and pregnancy. Current Hepatitis Reports 2009: 8; 91-5.
• 7. Recommendations of the Immunization Practices Advisory Committe. Prevention of perinatal transmission of hepatitis B virus: Prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR 1988; 37: 341-6.
• 8. Gambarin-Gelvan M. Hepatitis B in pregnancy. Clin. Liver Dis 2007; 11: 945-63.
• 9. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case control study. J Med Virol 2002; 67: 20-6.
• 10. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94- 103.